Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 209

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder

Iranzo, Alex, Santamaría, Joan, Valldeoriola, Francesc, Serradell, Monica, Salamero, Manel, Gaig, Carles, Niñerola‐Baizán, Aida, Sánchez‐Valle, Raquel, Lladó, Albert, De Marzi, Roberto, Stefani, Ambra, Seppi, Klaus, Pavia, Javier, Högl, Birgit, Poewe, Werner, Tolosa, Eduard, Lomeña, Francisco · 2017 · Annals of Neurology

Abstract

Objective: To determine the usefulness of dopamine transporter (DAT) imaging to identify idiopathic rapid eye movement sleep behavior disorder (IRBD) patients at risk for short‐term development of clinically defined synucleinopathy. Methods: Eighty‐seven patients with polysomnography‐confirmed IRBD underwent 123 I‐FP‐CIT DAT‐SPECT. Results were compared to 20 matched controls without RBD who underwent DAT‐SPECT. In patients, FP‐CIT uptake was considered abnormal when values were two standard deviations below controls’ mean uptake. After DAT‐SPECT, patients were followed up during 5.7 ± 2.2 (range, 2.6‐9.9) years. Results: Baseline DAT deficit was found in 51 (58.6%) patients. During follow‐up, 25 (28.7%) subjects developed clinically defined synucleinopathy (Parkinson's disease in 11, dementia with Lewy bodies in 13, and multiple system atrophy in 1) with mean latency of 3.2 ± 1.9 years from imaging. Kaplan‐Meier survival analysis showed increased risk of incident synucleinopathy in patients with abnormal DAT‐SPECT than with normal DAT‐SPECT (20% vs 6% at 3 years, 33% vs 18% at 5 years; log rank test, p = 0.006). Receiver operating characteristics curve revealed that reduction of FP‐CIT uptake in putamen greater than 25% discriminated patients with DAT deficit who developed synucleinopathy from patients with DAT deficit that remained disease free after 3 years of follow‐up. At 5‐year follow‐up, DAT‐SPECT had 75% sensitivity, 51% specificity, 44% positive predictive value, 80% negative predictive value, and likelihood ratio 1.54 to predict synucleinopathy. Interpretation: DAT‐SPECT identifies IRBD patients at short‐term risk for synucleinopathy. Decreased FP‐CIT putamen uptake greater than 25% predicts synucleinopathy after 3 years’ follow‐up. These observations may be useful to select candidates for disease modification trials in IRBD. Ann Neurol 2017;82:419–428

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25026

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 209

Metadata

Authors
Iranzo, A., Santamaría, J., Valldeoriola, F., Serradell, M., Salamero, M., Gaig, C., Niñerola‐Baizán, A., Sánchez‐Valle, R., Lladó, A., De Marzi, R., Stefani, A., Seppi, K., Pavia, J., Högl, B., Poewe, W., Tolosa, E., & Lomeña, F.
Venue
Annals of Neurology
Publisher
Wiley
Published
2017-09
Volume
82
Issue
3
Pages
419-428
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2776253469
Cited by
209
References
5
FWCI
12.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.